Northwest Biotherapeutics, Inc. (BST:NBYB)
0.2400
+0.0400 (20.00%)
At close: Jul 23, 2025
Northwest Biotherapeutics Employees
Northwest Biotherapeutics had 25 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
25
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
€54,513
Profits / Employee
€3,179,727
Market Cap
321.78M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 25 | 0 | - |
Dec 31, 2023 | 25 | 3 | 13.64% |
Dec 31, 2022 | 22 | 3 | 15.79% |
Dec 31, 2021 | 19 | 0 | - |
Dec 31, 2020 | 19 | 2 | 11.76% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
SAP SE | 109,121 |
Siemens Aktiengesellschaft | 327,000 |
Deutsche Telekom AG | 198,194 |
Allianz SE | 156,626 |
Rheinmetall AG | 28,539 |
Siemens Energy AG | 98,000 |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
Bayerische Motoren Werke Aktiengesellschaft | 159,104 |